Dieter Gericke

Homburger - Switzerland



+41 43 222 1518

Market leader


Bar admissions:




Practice areas:

Capital markets
Private equity

Dieter Gericke heads the Corporate | M&A team. He focuses on public and private mergers & acquisitions, private equity, capital markets (incl. IPOs) and finance. He advises in matters of corporate law and securities regulations. Dieter Gericke also heads the Homburger China Group.

  • Counsel to Infront on its acquisition of Youthstream, 2019;
  • Counsel to Bühler Group in the acquisition of Haas Group, 2018;
  • Counsel to ChemChina in the public takeover of Syngenta (USD 43 bn), 2018;
  • Counsel to the Underwriters in the USD 99.9 m rights offering and public offering by AC Immune SA , 2018;
  • Counsel to Temenos in the public offer for Fidessa (GBP 1.4 bn), 2018
  • Counsel to China National Chemical Corporation on its acquisition of Syngenta (USD 43 bn), 2018
  • Counsel to Bregal Unternehmerkapital in its acquisition of a majority stake in Kunststoff Schwanden AG, 2016.

  • Capital markets: Equity
  • M&A
  • Private equity
  • Restructuring and insolvency

  • Financial services
  • Food and beverage
  • Industrials
  • Pharma and life sciences
  • Tech and telecoms

  • At all Swiss courts

  • Zurich Bar Association
  • International Bar Association (Corporate and M&A Law Committee, Securities Law Committee)

  • lic. iur., University of Zurich, (1991)
  • Dr. iur., University of Zurich, (1996)
  • LL.M., Harvard Law School, (1999)